Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Global Womens Healthcare Market Size study & Forecast, by Drugs (Prolia, Xgeva, Evista, Mirena, Zometa, Reclast, Others), Application (Female Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraception, PCOS, Menopause) and Regional Analysis, 2022-2029
... valued approximately USD 12.30 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 13.2 % over the forecast period 2022-2029. Womens Healthcare defied as the branch of medicine ... Read More
-
Global Women’s Health Therapeutics Market Size study & Forecast, by Type( Infection, Pregnancy, Oncology) and Regional Analysis, 2022-2029
... grow with a healthy growth rate of more than 10.0% over the forecast period 2022-2029. Medical procedures, tools, and services aimed at identifying and enhancing women's health are referred to as therapeutics for women's health. ... Read More
-
Global Female Infertility Treatment Drugs Market Size study & Forecast, by Therapy( Gonadotropins, Clomiphene, Letrozole, Metformin , Leuprolide Acetate and Others) by Route of Administration( Oral and Injectable), by Distribution Channel ( Hospitals Pharmacies, Retail Pharmacies and Online Pharmacies) and Regional Analysis, 2022-2029
... Pharmacies and Online Pharmacies) and Regional Analysis, 2022-2029 Global Female Infertility Treatment Drugs Market is valued approximately USD 2,649.8 million in 2021 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
Angelman Syndrome (AS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 313,981 diagnosed prevalent cases of AS in 2023 in the 16 major markets. The marketed drugs space for AS is poor as there are no therapies currently approved for the treatment of the disease. R&D ... Read More
-
NGS Sample Preparation Market by Product (Reagents & Consumables, Workstations), Workflow (Library Prep, Target Enrichment), Sample Type (DNA), Application (Diagnostics, Drug Discovery), Method (Microfluidic, Automated), End User & Region - Global Forecast to 2028
... NGS sample preparation market is projected to reach USD 4.0 billion by 2028 from USD 1.9 billion in 2022, at a CAGR of 13.4% during the forecast period. The key factors driving the growth of ... Read More
-
Pet Cancer Therapeutics Market Size, By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, Combination Therapy), By Route of Administration (Oral, Injection), By Species (Dogs, Cats), By Application (Lymphoma, Mast Cell Cancer, Melanoma, Mammary, and Squamous Cell Cancer), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2032
... Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2032 Global Pet Cancer Therapeutics Market is speculated to grow considerably through 2032 owing to the surging pet care ... Read More
-
Global Parkinson's Disease Therapeutics Market Growth (Status and Outlook) 2023-2029
... 2022, providing a comprehensive analysis by region and market sector of projected Parkinson's Disease Therapeutics sales for 2023 through 2029. With Parkinson's Disease Therapeutics sales broken down by region, market sector and sub-sector, this report ... Read More
-
Global Pain Management Drugs & Devices Market Growth 2023-2029
... Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Pain Management Drugs & Devices sales for 2023 through 2029. With Pain Management Drugs & Devices sales broken down by ... Read More
-
Global Recurrent Glioblastoma Multiforme Treatment Market Growth (Status and Outlook) 2023-2029
... Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Recurrent Glioblastoma Multiforme Treatment sales for 2023 through 2029. With Recurrent Glioblastoma Multiforme Treatment sales broken down by region, market ... Read More
-
North American Finished Dosage Formulation Contract Manufacturing Market 2022-2028
... industry is driven by the contributions of drug manufacturers, research organizations, and pharmaceutical contract manufacturers. Outsourcing the manufacturing services in the pharmaceutical industry enables the companies to divert the workforce to other processing tasks, which, ... Read More
-
Fibrodysplasia Ossificans Progressiva (FOP) - Pipeline Insight, 2023
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder- Pipeline Insight, 2023
... landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline ... Read More
-
Bio-preservation Market Size, Share, and Analysis, By Product (Equipment [Freezers, Refrigerators, Liquid Nitrogen, Consumables], Media [Pre-formulated, Home-brew], Laboratory Information Management System); By Application (Regenerative Medicine, Bio-banking, Drug Discovery); By Cell Providers Volume (CD34+, CD19+, MSC, iPSC, HESC, Tumor Cells) and Regional Forecasts, 2022-2032.
... iPSC, hESC, Tumor Cells) and Regional Forecasts, 2022-2032 PRODUCT OVERVIEW Biopreservation is the process that maintains functionality & integrity of biological products like DNA, stem cells, tissues & organs under various temperatures for prolonging their ... Read More
-
Wet Age-related Macular Degeneration- Pipeline Insight, 2023
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Tuberculosis Treatment Drugs Market By Disease Type (Active Tuberculosis, Latent Tuberculosis), By Therapy Type (First Line Therapy, Second Line Therapy), By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers): Global Opportunity Analysis and Industry Forecast, 2021-2031
... and Industry Forecast, 2021-2031 The Tuberculosis Treatment Drugs Market valued for $1,929.96 million in 2021 and is estimated to reach $3,243.90 million by 2031, exhibiting a CAGR of 5.3% from 2022 to 2031. Tuberculosis (TB) ... Read More
-
Chronic Idiopathic Urticaria- Pipeline Insight, 2023
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
-
Ocular Hypertension- Pipeline Insight, 2023
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Ocular ... Read More
-
Chronic Inflammatory Demyelinating Polyneuropathy- Pipeline Insight, 2023
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2023
... Breast Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights ... Read More
-
Ewing Sarcoma Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Vincristine, Cyclophosphamide, Doxorubicin, Etoposide, Infoposide, Dactinomycin); By Treatment; By Application; By Region; Segment Forecast, 2023 - 2032
... market size is expected treach USD 424.42 million by 2032, according ta new study by Polaris Market Research. The report “Ewing Syndrome Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Vincristine, Cyclophosphamide, ... Read More
-
Guillain-Barre Syndrome- Pipeline Insight, 2023
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Guillain-Barre ... Read More
-
Non‐cystic fibrosis bronchiectasis - Pipeline Insight, 2023
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Dry Age-related Macular Degeneration- Pipeline Insight, 2023
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Delayed Onset Type 1 Diabetes
... a complete view of the market. Every MarketVue® includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter. Topics covered in this report: • Disease overview: Review ... Read More
-
Alzheimer'S Disease Diagnostics And Therapeutics Market - Growth, Trends And Forecasts (2023 - 2028)
... USD 9,639.23 million at the end of the forecast period, registering a growth with CAGR of 5.51% over the forecast period. The emergence of the COVID-19 pandemic impacted the Alzheimer's disease diagnostics and therapeutics market, ... Read More
Research Assistance
